logo-loader
RNS
viewAIM ImmunoTech Inc.

Medsea Estates Group - Director/PDMR Shareholding

RNS Number : 3442Y Medsea Estates Group PLC 04 July 2008 Medsea Estates Group plc ('Medsea' or 'the Company') Director/PDMR shareholding Medsea Estates Group plc (AIM: MEA), the Mediterranean-based property group, was notified today that Neil Craven, non-executive director, purchased 500,000 shares at 1p per share on Thursday 3rd July, increasing his holding in the Company to 1,550,000 shares representing 1.99% of the issued shares. This information is provided by RNS The company news service from the London Stock Exchange END RDSGCGDRRSGGGIS

Quick facts: AIM ImmunoTech Inc.

Price: 0.425

Market: NYSE
Market Cap: $3.51 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

RNS